IIPLA News
Wednesday, April 29, 2026

Munich UPC Division Clarifies Claim Interpretation for Medical Devices in Emboline v. AorticLab Dispute

Court finds no infringement of Emboline’s embolic protection device patent, emphasizing the significance of normal professional use in medical device claims.

IIPLA News Deskanonymous access0 articles left this week
UPC Claim Interpretation: The Normal Use Of A Medical Device Matters
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The Munich Local Division of the Unified Patent Court has ruled in favor of AorticLab srl, finding no infringement of Emboline Inc.'s patent for an embolic protection device. The decision underscores the importance of interpreting claim features in light of normal professional use, particularly for medical devices. Th…
Share This Article
Ready-to-post copy includes the article link.

Munich UPC Division Clarifies Claim Interpretation for Medical Devices in Emboline v. AorticLab Dispute The Munich Local Division of the Unified Patent Court has ruled in favor of AorticLab srl, finding no infringement of Emboline Inc.'s patent for an embolic protection device. The decision underscores the importance of i... Read the full IIPLA article: https://iipla.org/news/munich-upc-division-clarifies-claim-interpretation-for-medical-devices-in-emboline-v-aorticlab-dispute

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Thailand and Malaysia Piracy Ring Targeted in Joint DIP-Interpol Operation

The Department of Intellectual Property (DIP) of Thailand, in collaboration with Interpol, Malaysian and Korean police, and copyright owners, dismantled a cross-border piracy network distributing copyrighted films via subscription streaming. The operation, conducted in Chiang Mai, seized evidence and led to the arrest…

Friday, June 19, 2026
PatentsGlobal

Nokia and Lenovo Extend Their Patent Licensing Agreement

Nokia and Lenovo have officially renewed their patent licensing agreement, continuing their partnership in managing and licensing essential technology patents. This renewal underscores the ongoing strategic relationship between the two companies in the global technology sector.

Friday, June 19, 2026